PMI says it is the only company that has received modified risk tobacco product authorizations for heated tobacco products ...
In issuing the MRTP renewal orders for IQOS, the FDA reaffirmed that “ the scientific evidence that is available without conducting long-term epidemiological studies demonstrates that a measurable and ...
Zacks Investment Research on MSN
Philip Morris' IQOS retains FDA modified-risk authorization
Philip Morris International Inc. PMI has received renewed regulatory backing in the United States, as the Food and Drug ...
Business - The US Food and Drug Administration (FDA) has renewed the marketing authorisation for Philip Morris International ...
The Moodie Davitt Report was on location at Tortona Rocks in Milan as the ‘Soundsorial Design’ experience brought the ...
Tobacco giant Altria Group Inc. is planning a wider rollout of the IQOS device, an alternative to conventional cigarettes, even as the COVID-19 pandemic seems to have slowed a long-term decline in ...
In a move that blurs the lines between the Next Generation tobacco category and consumer electronics, PMI has partnered with ...
An Oct. 7 meeting was part of the FDA's review process of pending applications for IQOS ILUMA. "We encourage the FDA to continue efforts to establish a timely scientific review process for smoke-free ...
LAUSANNE, Switzerland--(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) today announced the launch of IQOS ILUMA i, the latest and most innovative addition to its growing portfolio ...
(Reuters) - At Germany's Bambi Awards for the media industry in November, celebrities posed for red-carpet photos against a backdrop of established luxury brands. Alongside the likes of Mercedes-Benz ...
NEW DELHI (Reuters) - Philip Morris International Inc is planning to launch its iQOS smoking device in India, four sources familiar with the matter told Reuters, as the tobacco giant seeks a foothold ...
Philip Morris International (NYSE: PM) has been a strong performer this year. The stock has fallen 20% from its high, yet shares are still up by more than 24% since January, outpacing the broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results